Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase.
Pivonello R, Fleseriu M, Newell-Price J, Bertagna X, Findling J, Shimatsu A, Gu F, Auchus R, Leelawattana R, Lee EJ, Kim JH, Lacroix A, Laplanche A, O'Connell P, Tauchmanova L, Pedroncelli AM, Biller BMK; LINC 3 investigators. Pivonello R, et al. Among authors: bertagna x. Lancet Diabetes Endocrinol. 2020 Sep;8(9):748-761. doi: 10.1016/S2213-8587(20)30240-0. Epub 2020 Jul 27. Lancet Diabetes Endocrinol. 2020. PMID: 32730798 Clinical Trial.
LCI699, a potent 11β-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study.
Bertagna X, Pivonello R, Fleseriu M, Zhang Y, Robinson P, Taylor A, Watson CE, Maldonado M, Hamrahian AH, Boscaro M, Biller BM. Bertagna X, et al. J Clin Endocrinol Metab. 2014 Apr;99(4):1375-83. doi: 10.1210/jc.2013-2117. Epub 2013 Dec 11. J Clin Endocrinol Metab. 2014. PMID: 24423285 Clinical Trial.
Cushing's syndrome.
Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Newell-Price J, et al. Among authors: bertagna x. Lancet. 2006 May 13;367(9522):1605-17. doi: 10.1016/S0140-6736(06)68699-6. Lancet. 2006. PMID: 16698415 Review.
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.
Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M. Biller BM, et al. Among authors: bertagna x. J Clin Endocrinol Metab. 2008 Jul;93(7):2454-62. doi: 10.1210/jc.2007-2734. Epub 2008 Apr 15. J Clin Endocrinol Metab. 2008. PMID: 18413427 Free PMC article. Review.
Cushing's disease.
Bertagna X, Guignat L, Groussin L, Bertherat J. Bertagna X, et al. Best Pract Res Clin Endocrinol Metab. 2009 Oct;23(5):607-23. doi: 10.1016/j.beem.2009.06.001. Best Pract Res Clin Endocrinol Metab. 2009. PMID: 19945026 Review.
Diagnosis and complications of Cushing's syndrome: a consensus statement.
Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M. Arnaldi G, et al. Among authors: bertagna x. J Clin Endocrinol Metab. 2003 Dec;88(12):5593-602. doi: 10.1210/jc.2003-030871. J Clin Endocrinol Metab. 2003. PMID: 14671138 Review.
Are Cushing's disease patients curable?
Bertagna X. Bertagna X. Ann Endocrinol (Paris). 2018 Jun;79(3):153-156. doi: 10.1016/j.ando.2018.03.012. Epub 2018 Apr 9. Ann Endocrinol (Paris). 2018. PMID: 29650226 Review.
292 results